These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 25384647)

  • 21. Aggression of C-difficile infections in PPI consumers.
    Daniell HW
    Am J Gastroenterol; 2014 Jun; 109(6):922. PubMed ID: 24896760
    [No Abstract]   [Full Text] [Related]  

  • 22. Proton pump inhibitors as a risk factor for paediatric Clostridium difficile infection.
    Turco R; Martinelli M; Miele E; Roscetto E; Del Pezzo M; Greco L; Staiano A
    Aliment Pharmacol Ther; 2010 Apr; 31(7):754-9. PubMed ID: 20047577
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence of Clostridium difficile associated diarrhoea in a tertiary care hospital.
    Kaneria MV; Paul S
    J Assoc Physicians India; 2012 Nov; 60():26-8. PubMed ID: 23767199
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Infection in solid-organ transplant recipients.
    Cross TJ; Berry PA; Burroughs AK
    N Engl J Med; 2008 Mar; 358(12):1302. PubMed ID: 18354113
    [No Abstract]   [Full Text] [Related]  

  • 25. Association between proton pump inhibitor therapy and Clostridium difficile infection in a meta-analysis.
    Deshpande A; Pant C; Pasupuleti V; Rolston DD; Jain A; Deshpande N; Thota P; Sferra TJ; Hernandez AV
    Clin Gastroenterol Hepatol; 2012 Mar; 10(3):225-33. PubMed ID: 22019794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk factors for Clostridium difficile-associated diarrhea among hospitalized adults with fecal toxigenic C. difficile colonization.
    Lin HJ; Hung YP; Liu HC; Lee JC; Lee CI; Wu YH; Tsai PJ; Ko WC
    J Microbiol Immunol Infect; 2015 Apr; 48(2):183-9. PubMed ID: 24064285
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clostridium difficile-associated diarrhea and proton pump inhibitor therapy: a meta-analysis.
    Janarthanan S; Ditah I; Adler DG; Ehrinpreis MN
    Am J Gastroenterol; 2012 Jul; 107(7):1001-10. PubMed ID: 22710578
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Adverse effects of long-term proton-pump inhibitor therapy on adults].
    Igaz I; Simonyi G; Balogh S; Szathmári M
    Orv Hetil; 2018 May; 159(19):735-740. PubMed ID: 29730946
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proton pump inhibitor use and recurrent Clostridium difficile-associated disease: a case-control analysis matched by propensity score.
    Kim YG; Graham DY; Jang BI
    J Clin Gastroenterol; 2012; 46(5):397-400. PubMed ID: 22298089
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overuse and inappropriate prescribing of proton pump inhibitors in patients with Clostridium difficile-associated disease.
    Choudhry MN; Soran H; Ziglam HM
    QJM; 2008 Jun; 101(6):445-8. PubMed ID: 18411220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proton Pump Inhibitors and the Risk for Hospital-Acquired Clostridium difficile Infection.
    Barletta JF; El-Ibiary SY; Davis LE; Nguyen B; Raney CR
    Mayo Clin Proc; 2013 Oct; 88(10):1085-90. PubMed ID: 24012413
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The importance of quality appraisal in meta-analysis.
    Mahady SE; Webster AC
    Clin Gastroenterol Hepatol; 2012 Sep; 10(9):1057; author reply 1057-8. PubMed ID: 22503999
    [No Abstract]   [Full Text] [Related]  

  • 33. Differential risk of Clostridium difficile infection with proton pump inhibitor use by level of antibiotic exposure.
    Stevens V; Dumyati G; Brown J; Wijngaarden E
    Pharmacoepidemiol Drug Saf; 2011 Oct; 20(10):1035-42. PubMed ID: 21833992
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence of Clostridium difficile infections in patients receiving antimicrobial and acid-suppression therapy.
    King RN; Lager SL
    Pharmacotherapy; 2011 Jul; 31(7):642-8. PubMed ID: 21923450
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clostridium difficile.
    Della-Torre E; Dagna L; Saporiti N
    N Engl J Med; 2009 Feb; 360(6):637; author reply 637-8. PubMed ID: 19202583
    [No Abstract]   [Full Text] [Related]  

  • 36. [Proton pump inhibitors are suspected of serious adverse effects. More cautious prescribing should be considered and on correct indications].
    Backman L; Schmidt D; Vitols S
    Lakartidningen; 2013 Apr 17-23; 110(16):828-31. PubMed ID: 23717929
    [No Abstract]   [Full Text] [Related]  

  • 37. Gastric acid suppression by proton pump inhibitors as a risk factor for clostridium difficile-associated diarrhea in hospitalized patients.
    Aseeri M; Schroeder T; Kramer J; Zackula R
    Am J Gastroenterol; 2008 Sep; 103(9):2308-13. PubMed ID: 18702653
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discussion.
    Surgery; 2014 Oct; 156(4):978. PubMed ID: 25151554
    [No Abstract]   [Full Text] [Related]  

  • 39. Continuous Proton Pump Inhibitor Therapy and the Associated Risk of Recurrent Clostridium difficile Infection.
    McDonald EG; Milligan J; Frenette C; Lee TC
    JAMA Intern Med; 2015 May; 175(5):784-91. PubMed ID: 25730198
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Considerations for the use of proton-pump inhibitors in older adults.
    Desilets AR; Asal NJ; Dunican KC
    Consult Pharm; 2012 Feb; 27(2):114-20. PubMed ID: 22330952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.